Transient Increase of Pre-existing Anti-IFN-α2 Antibodies Induced by SARS-CoV-2 Infection
Authors:
- Leuven COVID-Study GroupLGLeuven COVID-Study Group
- Maaike CockxMCMaaike Cockx
- Glynis FransGFGlynis Frans
- Maya ImbrechtsMIMaya Imbrechts
- Doreen DillaertsDDDoreen Dillaerts
- Isabelle MeytsIMIsabelle Meyts
- Nick GeukensNGNick Geukens
- Els WautersEWEls Wauters
- Pieter VermeerschPVPieter Vermeersch
- Joost WautersJWJoost Wauters
- 17 March 2022
- journal article
- letter
- Published by Springer Nature in Journal of Clinical Immunology
- Vol. 42 (4) , 742-745
Abstract
No abstract availableFunding Information
- KU Leuven
- Universitaire Ziekenhuizen Leuven, KU Leuven
This publication has 6 references indexed in Scilit:
- Temporal Dynamics of Anti–Type 1 Interferon Autoantibodies in Patients With Coronavirus Disease 2019Clinical Infectious Diseases, 2021
- Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deathsScience Immunology, 2021
- Autoantibodies against type I IFNs in patients with life-threatening COVID-19Science, 2020
- Profile of Immunoglobulin G and IgM Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)Clinical Infectious Diseases, 2020
- A rapid, accurate and robust particle-based assay for the simultaneous screening of plasma samples for the presence of five different anti-cytokine autoantibodiesJournal of Immunological Methods, 2015
- Characterization of the immunoreactivity of anti-interferon alpha antibodies in myasthenia gravis patients. Epitope mappingJournal of Autoimmunity, 2004